In order to establish whether the expression of autophagy markers could have an impact on breast cancer prognosis, we investigated their relation to relapse-free survival (RFS) in patients with ER– PR− and HER2− tumors (Figure 6E,F). The gene discussed is ERBB2; the disease is breast carcinoma.